Odds are clearly in $CMRX a favor. If you look at history - So since 2015, every drug that used and had supportive natural history data in oncology was approved

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

これかな

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @BenWestphalen: Super interesting topic covered in this #Researchpaper in @CCR_AACR : How did real world evidence support #oncology prod…

RT @BenWestphalen: Super interesting topic covered in this #Researchpaper in @CCR_AACR : How did real world evidence support #oncology prod…

RT @BenWestphalen: Super interesting topic covered in this #Researchpaper in @CCR_AACR : How did real world evidence support #oncology prod…

Super interesting topic covered in this #Researchpaper in @CCR_AACR : How did real world evidence support #oncology product registration from 2015-2020? If you ever had this question - find answers below 👇🏼 @OncoAlert 🚨#PrecisionMedicine #openaccess 🤩 ht

RT @TrueDiagnostics: Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biolo…

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020 https://t.co/ck0BDWDHhW

RT @PfizerOncMed: Patient data from the real world (Real-World Evidence [RWE]) is of interest to the FDA. Read a study in @CCR_AACR that ex…

RT @PfizerOncMed: Patient data from the real world (Real-World Evidence [RWE]) is of interest to the FDA. Read a study in @CCR_AACR that ex…

Patient data from the real world (Real-World Evidence [RWE]) is of interest to the FDA. Read a study in @CCR_AACR that explores the role of #RWE in FDA’s oncology therapy decision-making and best practices for FDA regulatory applications with #RWE https://

RT @CancerCureNow: Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologi…

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020 https://t.co/lCz0hdKXAx

Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020 https://t.co/1ZTgB8g8zs

RWE/RWDの利活用ってなかなか夢のある話なんだけど国際共同治験で各国地域でデータ共有をする場合に海外への情報持ち出し規制が懸念点よな。規制要件を擦り合わせてかないと。 https://t.co/MT2YiWytQf

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

RT @RUT_hhshark: これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のF…

これ重要 オンコロジーでRWD活用しFDA承認申請した試験のReviewと考察 /Clinical Cancer Research https://t.co/69XKk3S5xK 13試験の分析がTable2に、Discussionで各試験のFDAの解釈がまとまってます FDAは厳しく批判しつつもRWEを承認申請に活用すること、 外部比較対照研究の可能性も認めてる

RT @CancerCureNow: Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologi…

Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020 https://t.co/bE2mwQpVU9

RT @BenWestphalen: Where do we stand on #RealWorldEvidence in support of therapeutics in #Oncology ? A systematic review in ⁦@CCR_AACR⁩ t…

RT @BenWestphalen: Where do we stand on #RealWorldEvidence in support of therapeutics in #Oncology ? A systematic review in ⁦@CCR_AACR⁩ t…

Where do we stand on #RealWorldEvidence in support of therapeutics in #Oncology ? A systematic review in ⁦@CCR_AACR⁩ tackles this question 👇🏼 ⁦@OncoAlert⁩ 🚨 #cancerresearch https://t.co/vUVtPlqZya

RT @CancerCureNow: Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologi…

Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020 https://t.co/phk8O4JQhE